• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

病毒性心肌炎的心律失常基质是什么?来自临床和动物研究的见解。

What Is the Arrhythmic Substrate in Viral Myocarditis? Insights from Clinical and Animal Studies.

作者信息

Tse Gary, Yeo Jie M, Chan Yin Wah, Lai Eric T H Lai, Yan Bryan P

机构信息

Li Ka Shing Faculty of Medicine, School of Biomedical Sciences, University of Hong KongHong Kong, China; Department of Medicine and Therapeutics, The Chinese University of Hong KongHong Kong, China.

Faculty of Medicine, Imperial College London London, UK.

出版信息

Front Physiol. 2016 Jul 21;7:308. doi: 10.3389/fphys.2016.00308. eCollection 2016.

DOI:10.3389/fphys.2016.00308
PMID:27493633
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4954848/
Abstract

Sudden cardiac death (SCD) remains an unsolved problem in the twenty-first century. It is often due to rapid onset, ventricular arrhythmias caused by a number of different clinical conditions. A proportion of SCD patients have identifiable diseases such as cardiomyopathies, but for others, the causes are unknown. Viral myocarditis is becoming increasingly recognized as a contributor to unexplained mortality, and is thought to be a major cause of SCD in the first two decades of life. Myocardial inflammation, ion channel dysfunction, electrophysiological, and structural remodeling may play important roles in generating life-threatening arrhythmias. The aim of this review article is to examine the electrophysiology of action potential conduction and repolarization and the mechanisms by which their derangements lead to triggered and reentrant arrhythmogenesis. By synthesizing experimental evidence from pre-clinical and clinical studies, a framework of how host (inflammation), and viral (altered cellular signaling) factors can induce ion electrophysiological and structural remodeling is illustrated. Current pharmacological options are mainly supportive, which may be accompanied by mechanical circulatory support. Heart transplantation is the only curative option in the worst case scenario. Future strategies for the management of viral myocarditis are discussed.

摘要

心脏性猝死(SCD)在21世纪仍是一个未解决的问题。它通常是由于多种不同临床状况导致的快速发作的室性心律失常。一部分SCD患者有可识别的疾病,如心肌病,但对其他患者来说,病因不明。病毒性心肌炎越来越被认为是不明原因死亡的一个因素,并且被认为是20岁前SCD的主要原因。心肌炎症、离子通道功能障碍、电生理和结构重塑可能在产生危及生命的心律失常中起重要作用。这篇综述文章的目的是研究动作电位传导和复极化的电生理学,以及它们的紊乱导致触发和折返性心律失常发生的机制。通过综合临床前和临床研究的实验证据,阐述了宿主(炎症)和病毒(细胞信号改变)因素如何诱导离子电生理和结构重塑的框架。目前的药物选择主要是支持性的,可能会伴有机械循环支持。在最坏的情况下,心脏移植是唯一的治愈选择。本文还讨论了病毒性心肌炎未来的治疗策略。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e7/4954848/8f394beaa7c0/fphys-07-00308-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e7/4954848/99158a2f6827/fphys-07-00308-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e7/4954848/5a66cc773a82/fphys-07-00308-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e7/4954848/8f394beaa7c0/fphys-07-00308-g0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e7/4954848/99158a2f6827/fphys-07-00308-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e7/4954848/5a66cc773a82/fphys-07-00308-g0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40e7/4954848/8f394beaa7c0/fphys-07-00308-g0003.jpg

相似文献

1
What Is the Arrhythmic Substrate in Viral Myocarditis? Insights from Clinical and Animal Studies.病毒性心肌炎的心律失常基质是什么?来自临床和动物研究的见解。
Front Physiol. 2016 Jul 21;7:308. doi: 10.3389/fphys.2016.00308. eCollection 2016.
2
Abnormalities in sodium current and calcium homoeostasis as drivers of arrhythmogenesis in hypertrophic cardiomyopathy.钠电流和钙稳态异常作为肥厚型心肌病心律失常发生的驱动因素。
Cardiovasc Res. 2020 Jul 15;116(9):1585-1599. doi: 10.1093/cvr/cvaa124.
3
Ryanodine receptor 2 inhibition reduces dispersion of cardiac repolarization, improves contractile function, and prevents sudden arrhythmic death in failing hearts.ryanodine 受体 2 抑制可减少心脏复极的离散度,改善收缩功能,并预防衰竭心脏中的心律失常性猝死。
Elife. 2023 Dec 11;12:RP88638. doi: 10.7554/eLife.88638.
4
Sudden Cardiac Death in Diabetes and Obesity: Mechanisms and Therapeutic Strategies.糖尿病与肥胖相关的心脏性猝死:发病机制与治疗策略
Can J Cardiol. 2022 Apr;38(4):418-426. doi: 10.1016/j.cjca.2022.01.001. Epub 2022 Jan 10.
5
Secondary Prevention of Potentially Life-Threatening Arrhythmia Using Implantable Cardioverter Defibrillators in Patients with Biopsy-Proven Viral Myocarditis and Preserved Ejection Fraction.应用植入式心脏复律除颤器预防活检证实的病毒性心肌炎伴射血分数保留患者的潜在威胁生命的心律失常的二级预防。
Cardiology. 2021;146(2):213-221. doi: 10.1159/000511120. Epub 2021 Feb 5.
6
Incidence, risk assessment and prevention of sudden cardiac death in cardiomyopathies.扩张型心肌病、肥厚型心肌病、限制型心肌病和致心律失常性右室心肌病中的心源性猝死发生率、风险评估和预防。
Eur J Heart Fail. 2023 Dec;25(12):2144-2163. doi: 10.1002/ejhf.3076. Epub 2023 Nov 14.
7
Molecular biology and cellular mechanisms of Brugada and long QT syndromes in infants and young children.婴幼儿Brugada综合征和长QT综合征的分子生物学及细胞机制
J Electrocardiol. 2001;34 Suppl:177-81. doi: 10.1054/jelc.2001.28865.
8
Sudden cardiac death in patients with myocarditis: Evaluation, risk stratification, and management.心肌炎患者的心脏性猝死:评估、危险分层与管理。
Am Heart J. 2020 Feb;220:29-40. doi: 10.1016/j.ahj.2019.08.007. Epub 2019 Aug 15.
9
Electrophysiological alterations in a murine model of chronic coxsackievirus B3 myocarditis.慢性柯萨奇病毒B3心肌炎小鼠模型中的电生理改变
PLoS One. 2017 Jun 23;12(6):e0180029. doi: 10.1371/journal.pone.0180029. eCollection 2017.
10
Implantable cardioverter defibrillators. Prophylactic use: an evidence-based analysis.植入式心脏复律除颤器。预防性应用:基于证据的分析。
Ont Health Technol Assess Ser. 2005;5(14):1-74. Epub 2005 Sep 1.

引用本文的文献

1
COVID-19 and Cardiac Arrhythmias: Lesson Learned and Dilemmas.新冠病毒肺炎与心律失常:经验教训与困境
J Clin Med. 2024 Nov 29;13(23):7259. doi: 10.3390/jcm13237259.
2
Role of POCUS in the Management of New-onset Tachyarrhythmia in the Setting of SARS-CoV-2: A Case Report.床旁超声心动图在新型冠状病毒肺炎背景下新发快速性心律失常管理中的作用:一例报告
J Community Hosp Intern Med Perspect. 2023 Nov 4;13(6):50-53. doi: 10.55729/2000-9666.1261. eCollection 2023.
3
Cardiac Complications and COVID-19: A Review of Life-threatening Co-morbidities.

本文引用的文献

1
Atypical case of post-partum cardiomyopathy: an overlap syndrome with arrhythmogenic right ventricular cardiomyopathy?产后心肌病的非典型病例:与致心律失常性右室心肌病的重叠综合征?
BJR Case Rep. 2015 Jul 7;1(2):20150182. doi: 10.1259/bjrcr.20150182. eCollection 2015.
2
Determination of action potential wavelength restitution in mouse hearts modelling human Brugada syndrome.在模拟人类Brugada综合征的小鼠心脏中测定动作电位波长恢复情况。
J Geriatr Cardiol. 2017 Sep;14(9):595-596. doi: 10.11909/j.issn.1671-5411.2017.09.011.
3
(Tpeak - Tend)/QRS and (Tpeak - Tend)/(QT × QRS): novel markers for predicting arrhythmic risk in the Brugada syndrome.
心脏并发症与 COVID-19:危及生命的合并症综述。
Curr Cardiol Rev. 2024;20(3):1-12. doi: 10.2174/011573403X279782240206091322.
4
"When," "Where," and "How" of SARS-CoV-2 Infection Affects the Human Cardiovascular System: A Narrative Review.SARS-CoV-2 感染的“何时”“何地”和“如何”影响人体心血管系统:叙述性综述。
Balkan Med J. 2024 Jan 3;41(1):7-22. doi: 10.4274/balkanmedj.galenos.2023.2023-10-25.
5
COVID-19 and Arrhythmias: A Review of Cardiac Electrophysiology Associated with SARS-CoV-2.新型冠状病毒肺炎与心律失常:与严重急性呼吸综合征冠状病毒2相关的心脏电生理学综述
HCA Healthc J Med. 2020 Nov 28;1:355-359. doi: 10.36518/2689-0216.1133. eCollection 2020.
6
Biological Modification of Arrhythmogenic Substrates by Cell-Free Therapeutics.细胞游离治疗的心律失常基质的生物学修饰。
Heart Lung Circ. 2023 Jul;32(7):844-851. doi: 10.1016/j.hlc.2023.05.016. Epub 2023 Jun 22.
7
Advanced Temporally-Spatially Precise Technologies for On-Demand Neurological Disorder Intervention.按需干预神经疾病的先进时空精准技术。
Adv Sci (Weinh). 2023 May;10(14):e2207436. doi: 10.1002/advs.202207436. Epub 2023 Mar 16.
8
Cardiovascular Complications of Viral Respiratory Infections and COVID-19.病毒性呼吸道感染和新冠肺炎的心血管并发症
Biomedicines. 2022 Dec 27;11(1):71. doi: 10.3390/biomedicines11010071.
9
Cardiac Evaluation in Children with Multisystem Inflammatory Syndrome Associated with SARS-CoV-2.新型冠状病毒肺炎相关多系统炎症综合征患儿的心脏评估
Sisli Etfal Hastan Tip Bul. 2022 Dec 19;56(4):461-465. doi: 10.14744/SEMB.2022.23921. eCollection 2022.
10
Incidence of arrhythmias in COVID-19 patients with double mutant strain of SARS-CoV-2 virus: A tertiary care experience.感染严重急性呼吸综合征冠状病毒2(SARS-CoV-2)双突变株的2019冠状病毒病(COVID-19)患者的心律失常发生率:三级医疗中心的经验
Glob Cardiol Sci Pract. 2022 Dec 30;2022(3):e202216. doi: 10.21542/gcsp.2022.16.
(T峰 - T终末)/QRS及(T峰 - T终末)/(QT×QRS):预测Brugada综合征心律失常风险的新型标志物。
Europace. 2017 Apr 1;19(4):696. doi: 10.1093/europace/euw194.
4
Variability in local action potential durations, dispersion of repolarization and wavelength restitution in aged wild-type and Scn5a mouse hearts modeling human Brugada syndrome.老年野生型和模拟人类Brugada综合征的Scn5a小鼠心脏中局部动作电位持续时间的变异性、复极离散度和波长恢复情况。
J Geriatr Cardiol. 2016 Nov;13(11):930-931. doi: 10.11909/j.issn.1671-5411.2016.11.009.
5
Both transmural dispersion of repolarization and of refractoriness are poor predictors of arrhythmogenicity: a role for iCEB (QT/QRS)?复极和不应期的跨壁离散度均不能很好地预测致心律失常性:iCEB(QT/QRS)的作用?
J Geriatr Cardiol. 2016 Sep;13(9):813-814. doi: 10.11909/j.issn.1671-5411.2016.09.007.
6
Novel conduction-repolarization indices for the stratification of arrhythmic risk.用于心律失常风险分层的新型传导-复极指数。
J Geriatr Cardiol. 2016 Sep;13(9):811-812. doi: 10.11909/j.issn.1671-5411.2016.09.008.
7
Cardiac disease and arrhythmogenesis: Mechanistic insights from mouse models.心脏疾病与心律失常的发生机制:来自小鼠模型的机制性见解
Int J Cardiol Heart Vasc. 2016 Sep;12:1-10. doi: 10.1016/j.ijcha.2016.05.005.
8
Cardiac dynamics: Alternans and arrhythmogenesis.心脏动力学:交替变化与心律失常的发生机制
J Arrhythm. 2016 Oct;32(5):411-417. doi: 10.1016/j.joa.2016.02.009. Epub 2016 Mar 28.
9
Traditional and novel electrocardiographic conduction and repolarization markers of sudden cardiac death.心脏性猝死的传统及新型心电图传导和复极标志物
Europace. 2017 May 1;19(5):712-721. doi: 10.1093/europace/euw280.
10
Molecular and Electrophysiological Mechanisms Underlying Cardiac Arrhythmogenesis in Diabetes Mellitus.糖尿病中心律失常发生的分子和电生理机制
J Diabetes Res. 2016;2016:2848759. doi: 10.1155/2016/2848759. Epub 2016 Aug 23.